Health-Related Quality of Life in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients Treated with Either Thalidomide or Lenalidomide-Based Regimen Until Progression (HOVON-87/NMSG18 Study): A Prospective, Open-Label, Multicenter, Randomized, Phase 3 Study

SSRN Electronic Journal ◽

10.2139/ssrn.3337896 ◽

2019 ◽

Author(s):

Lene Kongsgaard Nielsen ◽

Claudia Stege ◽

Birgit Lissenberg-Witte ◽

Bronno van der Holt ◽

Ulf-Henrik Mellqvist ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Newly Diagnosed ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study

Haematologica ◽

10.3324/haematol.2019.222299 ◽

2019 ◽

Vol 105 (6) ◽

pp. 1650-1659 ◽

Cited By ~ 2

Author(s):

Lene Kongsgaard Nielsen ◽

Claudia Stege ◽

Birgit Lissenberg-Witte ◽

Bronno van der Holt ◽

Ulf-Henrik Mellqvist ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Newly Diagnosed ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text

Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial

The Lancet Haematology ◽

10.1016/s2352-3026(20)30356-2 ◽

2020 ◽

Vol 7 (12) ◽

pp. e874-e883

Author(s):

Murielle Roussel ◽

Philippe Moreau ◽

Benjamin Hebraud ◽

Kamel Laribi ◽

Arnaud Jaccard ◽

...

Keyword(s):

Quality Of Life ◽

Newly Diagnosed ◽

Health Related Quality ◽

Life Outcomes ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(19)30502-9 ◽

2019 ◽

Vol 20 (10) ◽

pp. 1444-1453 ◽

Cited By ~ 4

Author(s):

Johannes Weller ◽

Theophilos Tzaridis ◽

Frederic Mack ◽

Joachim Peter Steinbach ◽

Uwe Schlegel ◽

...

Keyword(s):

Quality Of Life ◽

Neurocognitive Functioning ◽

Newly Diagnosed ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽

Related Quality ◽

Health Related

Download Full-text

Faculty Opinions recommendation of Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969674.793470152 ◽

2013 ◽

Author(s):

Christopher Steer

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text

EFFECT OF DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE ON CARDIAC FUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH CARDIAC INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(21)04658-1 ◽

2021 ◽

Vol 77 (18) ◽

pp. 3304

Author(s):

Martha Grogan ◽

Mathew S. Maurer ◽

Ronald Witteles ◽

Divaya Bhutani ◽

Raymond L. Comenzo ◽

...

Keyword(s):

Quality Of Life ◽

Cardiac Function ◽

Cardiac Involvement ◽

Al Amyloidosis ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma

Leukemia & Lymphoma ◽

10.1080/10428194.2020.1747066 ◽

2020 ◽

Vol 61 (8) ◽

pp. 1850-1859

Author(s):

Katja Weisel ◽

Meletios Dimopoulos ◽

Philippe Moreau ◽

Munci Yagci ◽

Alessandra Larocca ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Low Dose ◽

Health Related Quality ◽

Phase 3 ◽

Refractory Multiple Myeloma ◽

Related Quality ◽

Health Related

Download Full-text

Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial

Annals of Hematology ◽

10.1007/s00277-011-1224-1 ◽

2011 ◽

Vol 90 (12) ◽

pp. 1427-1439 ◽

Cited By ~ 22

Author(s):

Silvia G. R. Verelst ◽

◽

F. Termorshuizen ◽

C. A. Uyl-de Groot ◽

M. R. Schaafsma ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Elderly Patients ◽

Randomized Trial ◽

Prospective Analysis ◽

Newly Diagnosed ◽

Health Related Quality ◽

Related Quality ◽

Health Related

Download Full-text

Effect of initial treatment on health‐related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect ® MM Registry

British Journal of Haematology ◽

10.1111/bjh.17131 ◽

2020 ◽

Author(s):

Rafat Abonour ◽

Robert M. Rifkin ◽

Cristina Gasparetto ◽

Kathleen Toomey ◽

Brian G. M. Durie ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Newly Diagnosed ◽

Health Related Quality ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma

Leukemia & Lymphoma ◽

10.1080/10428194.2020.1719091 ◽

2020 ◽

Vol 61 (6) ◽

pp. 1323-1333 ◽

Cited By ~ 2

Author(s):

Murielle Roussel ◽

Benjamin Hebraud ◽

Cyrille Hulin ◽

Aurore Perrot ◽

Denis Caillot ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Newly Diagnosed ◽

Health Related Quality ◽

Trial Treatment ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(17)30690-3 ◽

2017 ◽

Vol 18 (12) ◽

pp. 1600-1609 ◽

Cited By ~ 118

Author(s):

Julie R Brahmer ◽

Delvys Rodríguez-Abreu ◽

Andrew G Robinson ◽

Rina Hui ◽

Tibor Csőszi ◽

...

Keyword(s):

Quality Of Life ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽

Related Quality ◽

Health Related

Download Full-text